Literature DB >> 25455959

Surgical strategy for low rectal cancers.

F Dumont1, A Mariani2, D Elias2, D Goéré2.   

Abstract

The two goals of surgery for lower rectal cancer surgery are to obtain clear "curative" margins and to limit post-surgical functional disorders. The question of whether or not to preserve the anal sphincter lies at the center of the therapeutic choice. Histologically, tumor-free distal and circumferential margins of>1mm allow a favorable oncologic outcome. Whether such margins can be obtained depends of TNM staging, tumor location, response to chemoradiotherapy and type of surgical procedure. The technique of intersphincteric resection relies on these narrow margins to spare the sphincter. This procedure provides satisfactory oncologic outcome with a rate of circumferential margin involvement ranging from 5% to 11%, while good continence is maintained in half of the patients. The extralevator abdominoperineal resection provides good oncologic results, however this procedure requires a permanent colostomy. A permanent colostomy alters several domains of quality of life when located at the classical abdominal site but not when brought out at the perineal site as a perineal colostomy.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cancer; Clinical update; Intersphincteric resection; Low rectum; Perineal colostomy

Mesh:

Year:  2014        PMID: 25455959     DOI: 10.1016/j.jviscsurg.2014.10.005

Source DB:  PubMed          Journal:  J Visc Surg        ISSN: 1878-7886            Impact factor:   2.043


  2 in total

1.  Effect of Self-efficacy Intervention on Quality of Life of Patients With Intestinal Stoma.

Authors:  Shujuan Xu; Zhiyun Zhang; Aimei Wang; Jiangyun Zhu; Hongzhi Tang; Xiaoli Zhu
Journal:  Gastroenterol Nurs       Date:  2018 Jul/Aug       Impact factor: 0.978

2.  Efficacy and safety of wait and see strategy versus radical surgery and local excision for rectal cancer with cCR response after neoadjuvant chemoradiotherapy: a meta-analysis.

Authors:  Guo-Hua Zhao; Li Deng; Dong-Man Ye; Wen-Hui Wang; Yan Yan; Tao Yu
Journal:  World J Surg Oncol       Date:  2020-08-31       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.